You are here: Home » PTI Stories » National » News
Business Standard

Unichem Labs gets USFDA nod for arthritis drug

Press Trust of India  |  New Delhi 

Drug firm today said it has received approval from the US health regulator for Piroxicam Capsules, used in treatment of osteoarthritis and rheumatoid arthritis, in the US market.

In a filing, said "it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg and 20mg".



The approved product is therapeutically equivalent to Feldene Capsules 10mg and 20mg of Inc.

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA).

said the product will be commercialised from its plant.

"Active Pharmaceutical Ingredient will also be made in-house at Roha API Plant," it added.

of were trading 1.49 per cent higher at Rs 290 on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Unichem Labs gets USFDA nod for arthritis drug

Drug firm Unichem Laboratories today said it has received approval from the US health regulator for Piroxicam Capsules, used in treatment of osteoarthritis and rheumatoid arthritis, in the US market. In a BSE filing, Unichem Laboratories said "it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg and 20mg". The approved product is therapeutically equivalent to Feldene Capsules 10mg and 20mg of Pfizer Inc. Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). Unichem Laboratories said the product will be commercialised from its Goa plant. "Active Pharmaceutical Ingredient will also be made in-house at Roha API Plant," it added. Shares of Unichem Laboratories were trading 1.49 per cent higher at Rs 290 on BSE. Drug firm today said it has received approval from the US health regulator for Piroxicam Capsules, used in treatment of osteoarthritis and rheumatoid arthritis, in the US market.

In a filing, said "it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg and 20mg".

The approved product is therapeutically equivalent to Feldene Capsules 10mg and 20mg of Inc.

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA).

said the product will be commercialised from its plant.

"Active Pharmaceutical Ingredient will also be made in-house at Roha API Plant," it added.

of were trading 1.49 per cent higher at Rs 290 on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Unichem Labs gets USFDA nod for arthritis drug

Drug firm today said it has received approval from the US health regulator for Piroxicam Capsules, used in treatment of osteoarthritis and rheumatoid arthritis, in the US market.

In a filing, said "it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg and 20mg".

The approved product is therapeutically equivalent to Feldene Capsules 10mg and 20mg of Inc.

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA).

said the product will be commercialised from its plant.

"Active Pharmaceutical Ingredient will also be made in-house at Roha API Plant," it added.

of were trading 1.49 per cent higher at Rs 290 on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22